BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
Chirocaine considered approvable by FDA, rights return to Chiroscience
March 2, 1999
Favorable phase I results reported for GT-2331 as single doses
March 2, 1999
AHP describes new dopamine autoreceptor agonists in patent literature
March 2, 1999
Orion signs licensing agreement with R.P. Scherer for Zydis apomorphine
March 2, 1999
Oral interferon to enter human trials for MS
March 2, 1999
French investigators describe potent and selective dopamine D3 agonists
March 1, 1999
Potent nAChR receptor agonists with heterocyclic structure patented by Astra
March 1, 1999
CNS compounds from Merck acting on serotonergic system
Feb. 26, 1999
Novel BK channel modulators developed at Bristol-Myers Squibb
Feb. 26, 1999
AutoImmune and Teva to collaborate on oral immune therapies
Feb. 25, 1999
Previous
1
2
…
2729
2730
2731
2732
2733
2734
2735
2736
2737
…
3010
3011
Next
RSS